These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Quinazoline-2-Carboxamides as Selective PET Radiotracers for Matrix Metalloproteinase-13 Imaging in Atherosclerosis. Buchler A; Ismailani US; MacMullin N; Abdirahman F; Adi M; Bi C; Jany C; Keillor JW; Rotstein BH J Med Chem; 2023 May; 66(10):6682-6696. PubMed ID: 37158732 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of [ Kiugel M; Hellberg S; Käkelä M; Liljenbäck H; Saanijoki T; Li XG; Tuomela J; Knuuti J; Saraste A; Roivainen A Molecules; 2018 Dec; 23(12):. PubMed ID: 30513758 [No Abstract] [Full Text] [Related]
4. Preclinical evaluation of an Park JY; Kim HJ; Chae JR; Cho YL; Kang WJ Biochem Biophys Res Commun; 2024 Apr; 703():149650. PubMed ID: 38377941 [TBL] [Abstract][Full Text] [Related]
5. NOS3 prevents MMP-9, and MMP-13 induced extracellular matrix proteolytic degradation through specific microRNA-targeted expression of extracellular matrix metalloproteinase inducer in hypertension-related atherosclerosis. Ramírez-Carracedo R; Hernández I; Moreno-Gómez-Toledano R; Díez-Mata J; Tesoro L; González-Cucharero C; Jiménez-Guirado B; Alcharani N; Botana L; Saura M; Zamorano JL; Zaragoza C J Hypertens; 2024 Apr; 42(4):685-693. PubMed ID: 38406874 [TBL] [Abstract][Full Text] [Related]
6. Cannabinoid receptor type 2 (CB2) as one of the candidate genes in human carotid plaque imaging: Evaluation of the novel radiotracer [ Meletta R; Slavik R; Mu L; Rancic Z; Borel N; Schibli R; Ametamey SM; Krämer SD; Müller Herde A Nucl Med Biol; 2017 Apr; 47():31-43. PubMed ID: 28104528 [TBL] [Abstract][Full Text] [Related]
7. Human antibody against C domain of tenascin-C visualizes murine atherosclerotic plaques ex vivo. von Lukowicz T; Silacci M; Wyss MT; Trachsel E; Lohmann C; Buck A; Lüscher TF; Neri D; Matter CM J Nucl Med; 2007 Apr; 48(4):582-7. PubMed ID: 17401095 [TBL] [Abstract][Full Text] [Related]
8. Positron Emission Tomography Imaging of Macrophages in Atherosclerosis with Hellberg S; Liljenbäck H; Eskola O; Morisson-Iveson V; Morrison M; Trigg W; Saukko P; Ylä-Herttuala S; Knuuti J; Saraste A; Roivainen A Contrast Media Mol Imaging; 2018; 2018():9186902. PubMed ID: 29950954 [TBL] [Abstract][Full Text] [Related]
9. Gene expression levels of matrix metalloproteinases in human atherosclerotic plaques and evaluation of radiolabeled inhibitors as imaging agents for plaque vulnerability. Müller A; Krämer SD; Meletta R; Beck K; Selivanova SV; Rancic Z; Kaufmann PA; Vos B; Meding J; Stellfeld T; Heinrich TK; Bauser M; Hütter J; Dinkelborg LM; Schibli R; Ametamey SM Nucl Med Biol; 2014 Aug; 41(7):562-9. PubMed ID: 24853402 [TBL] [Abstract][Full Text] [Related]
12. Molecular Imaging of Matrix Metalloproteinase-2 in Atherosclerosis Using a Smart Multifunctional PET/MRI Nanoparticle. Tu Y; Ma X; Chen H; Fan Y; Jiang L; Zhang R; Cheng Z Int J Nanomedicine; 2022; 17():6773-6789. PubMed ID: 36600879 [TBL] [Abstract][Full Text] [Related]
13. 18-kDa translocator protein ligand Hellberg S; Silvola JMU; Kiugel M; Liljenbäck H; Savisto N; Li XG; Thiele A; Lehmann L; Heinrich T; Vollmer S; Hakovirta H; Laine VJO; Ylä-Herttuala S; Knuuti J; Roivainen A; Saraste A J Nucl Cardiol; 2017 Jun; 24(3):862-871. PubMed ID: 27225517 [TBL] [Abstract][Full Text] [Related]
14. Effects of age, diet, and type 2 diabetes on the development and FDG uptake of atherosclerotic plaques. Silvola JM; Saraste A; Laitinen I; Savisto N; Laine VJ; Heinonen SE; Ylä-Herttuala S; Saukko P; Nuutila P; Roivainen A; Knuuti J JACC Cardiovasc Imaging; 2011 Dec; 4(12):1294-301. PubMed ID: 22172786 [TBL] [Abstract][Full Text] [Related]
15. P2X7 receptor-specific radioligand Fu Z; Lin Q; Xu Z; Zhao Y; Cheng Y; Shi D; Fu W; Yang T; Shi H; Cheng D Eur J Nucl Med Mol Imaging; 2022 Jul; 49(8):2595-2604. PubMed ID: 35048153 [TBL] [Abstract][Full Text] [Related]
16. Matrix metalloproteinase-13 predominates over matrix metalloproteinase-8 as the functional interstitial collagenase in mouse atheromata. Quillard T; Araújo HA; Franck G; Tesmenitsky Y; Libby P Arterioscler Thromb Vasc Biol; 2014 Jun; 34(6):1179-86. PubMed ID: 24723558 [TBL] [Abstract][Full Text] [Related]
17. Molecular Imaging of Inflammation in a Mouse Model of Atherosclerosis Using a Zirconium-89-Labeled Probe. Ahmed M; Tegnebratt T; Tran TA; Lu L; Damberg P; Gisterå A; Tarnawski L; Bone D; Hedin U; Eriksson P; Holmin S; Gustafsson B; Caidahl K Int J Nanomedicine; 2020; 15():6137-6152. PubMed ID: 32884268 [TBL] [Abstract][Full Text] [Related]
18. Comparison of Somatostatin Receptor 2-Targeting PET Tracers in the Detection of Mouse Atherosclerotic Plaques. Rinne P; Hellberg S; Kiugel M; Virta J; Li XG; Käkelä M; Helariutta K; Luoto P; Liljenbäck H; Hakovirta H; Gardberg M; Airaksinen AJ; Knuuti J; Saraste A; Roivainen A Mol Imaging Biol; 2016 Feb; 18(1):99-108. PubMed ID: 26122428 [TBL] [Abstract][Full Text] [Related]
19. Type 2 diabetes enhances arterial uptake of choline in atherosclerotic mice: an imaging study with positron emission tomography tracer ¹⁸F-fluoromethylcholine. Hellberg S; Silvola JM; Kiugel M; Liljenbäck H; Metsälä O; Viljanen T; Metso J; Jauhiainen M; Saukko P; Nuutila P; Ylä-Herttuala S; Knuuti J; Roivainen A; Saraste A Cardiovasc Diabetol; 2016 Feb; 15():26. PubMed ID: 26852231 [TBL] [Abstract][Full Text] [Related]
20. Immuno-PET Imaging of Atherosclerotic Plaques with [ Poels K; Schreurs M; Jansen M; Vugts DJ; Seijkens TTP; van Dongen GAMS; Lutgens E; Beaino W Biology (Basel); 2022 Mar; 11(3):. PubMed ID: 35336782 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]